PCOS Has a New Name; Doctors Hope It Will Improve Care for Millions

Doctors officially renamed polycystic ovary syndrome (PCOS) to polyendocrine metabolic ovarian syndrome (PMOS) because the old name focused too narrowly on ovarian cysts while ignoring the condition's widespread metabolic and hormone disruption Researchers found that insulin resistance affects about 85% of women with PMOS, including many women with normal body weight, helping explain why symptoms like acne, irregular periods, facial hair growth, and weight gain often appear together The condition is associated with increased risk of serious long-term health problems, including Type 2 diabetes, fatty liver disease, high blood pressure, heart attack, and stroke, showing that PMOS extends far beyond reproductive health Gut dysfunction and chronic inflammation are linked to hormone imbalance in PMOS. Postbiotics from beneficial bacteria such as Akkermansia muciniphila may help strengthen the gut barrier, support insulin sensitivity, and calm inflammatory stress Daily movement, whole-food carbohydrates, stress reduction, sunlight exposure, and lowering exposure to seed oils and hormone-disrupting plastics may support metabolic health in women with PMOS